vVARDIS completes $175M NYSE IPO: Nov 13 trading, Nov 16 legal close
vVARDIS completes $175M NYSE IPO: Nov 13 trading, Nov 16 legal close
vVARDIS Holding AG priced 9,722,223 Class A ordinary shares at $18 per share in its November 2026 NYSE IPO (VVVV), yielding exactly $175,000,014 base GROSS offering proceeds before underwriting deductions and expenses. Trading began on November 13, 2026. The issuer's signed SEC Form 6-K dated November 16 confirms the IPO LEGALLY CLOSED on November 16, with the same 9,722,223 base shares. Underwriters' separately disclosed 30-day option for up to 1,458,333 additional shares was not represented as exercised in this filing; exclude it from base proceeds. Historical OrbiMed financing in 2025 ($35M then $50M) is unrelated to IPO proceeds and its debt/equity instrument split must not be invented. This canonical event retains the original trading-debut eventDate and stable eventKey.